Abstract
Cytokines are small, non-structural proteins with molecular weights ranging from 8–40,000 Daltons. Originally called lymphokines and monokines to indicate their cellular sources, it became clear that the term “cytokine” is the best description since nearly all nucleated cells are capable of synthesising of these proteins and, in turn, respond to them. There is no amino acid sequence motif or three dimensional structure that links cytokines; rather, their biological activities allow us to group them into different classes. For the most part, cytokines are primarily involved in host responses to disease or infection and any involvement with homeostatic mechanisms has been less than dramatic. At least that is the present wisdom derived from gene deletion studies in mice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schweizer A, Feige U, Fontana A, Muller K, Dinarello CA (1988) Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels. Agents Actions 25: 246–251
Janik JE, Miller LL, Longo DL, Powers GC, Urba WJ, Kopp WC, Gause BL, Curti BD, Fenton RG, Oppenheim JJ, Conlon KC, Holmlund JT, Sznol M, Sharfman WH, Steis RG, Creekmore SP, Alvord WG, Beauchamp AE, Smith JW 2nd (1996) Phase II trial of interleukin 1 alpha and indomethacin in treatment of metastatic melanoma. J Natl Cancer Inst 88. 44–49
Libby P, Warner SJ, Friedman GB (1988) Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 81: 487–498
Breder CD, Dinarello CA, Saper CB (1988) Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 240: 321–324
Sims JE, Giri JG, Dower SK (1994) The two interleukin-1 receptors play different roles in IL-1 activities. Clin Immunol Immunopathol 72: 9–14
Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G (1995) Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J Biol Chem 270: 13757–13765
Sims JE, Painter SL, Gow IR (1995) Genomic organization of the type I and type II IL-1 receptors. Cytokine 7: 483–490
Mancilla J, Ikejima I, Dinarello CA (1992) Glycosylation of the interleukin-1 receptor type I is required for optimal binding of interleukin-1. Lymphokine Cytokine Res 11: 197–205
Rosoff PM, Savage N, Dinarello CA (1988) Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism. Cell 54: 73–81
Gay NJ, Keith FJ (1991) Drosophila Toll and IL-1 receptor. Nature 351: 355–356
Heguy A, Baldari CT, Macchia G, Telford JL, Melli M (1992) Amino acids conserved in interleukin-1 receptors and the Drosophila Toll protein are essential for IL-1R signal transduction. J Biol Chem 267: 2605–2609
Vigers GPA, Anderson LJ, Caffes P, Brandhuber BJ (1997) Crystal structure of the type I interleukin-1 receptor complexed with interleukin-1β. Nature 386: 190–194
Evans RJ, Bray J, Childs JD, Vigers GP, Brandhuber BJ, Skalicky JJ, Thompson RC, Eisenberg SP (1995) Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis: identification of a single site in IL-1ra and two sites in IL-1 beta. J Biol Chem 270 (19): 11477–11483
Schreuder H, Tardif C, Trump-Kallmeyer S, Soffientini A, Sarubbi E, Akeson A, Bowlin T, Yanofsky S, Barrett RW (1997) A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 386 (6621): 194–200
Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin MU (1997) The interleukin1 receptor accessory protein is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem 272: 7727–7731
Yoon D-Y, Dinarello CA (1996) Regulation of IL-1 receptor tyep I and accessory protein by IL-10. Eur Cytokine Netw 7: 547 (abs)
Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A (1993) Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261: 472–475
Heguy A, Baldari CT, Censini S, Ghiara P, Telford JL (1993) A chimeric type II/I interleukin-1 receptor can mediate interleukin-1 induction of gene expression in T cells. J Biol Chem 268: 10490–10494
Giri J, Newton RC, Horuk R (1990) Identification of soluble interleukin-1 binding protein in cell-free supernatants. J Biol Chem 265: 17416–17419
Symons JA, Eastgate JA, Duff GW (1991) Purification and characterization of a novel soluble receptor for interleukin-1. J Exp Med 174: 1251–1254
Symons JA, Young PA, Duff GW (1993) The soluble interleukin-1 receptor: ligand binding properties and mechanisms of release. Lymphokine Cytokine Res 12: 381
Arend WP, Malyak M, Smith MF Jr, Whisenand TD, Slack JL, Sims JE, Giri JG, Dower SK (1994) Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol 153 (10): 4766–4774
Giri JG, Wells J, Dower SK, McCall CE, Guzman RN, Slack J, Bird TA, Shanebeck K, Grabstein KH, Sims JE (1994) Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type Il receptor in regulation of IL-1 responses. J Immunol 153 (12): 5802–5809
Crown J, Jakubowski A, Kemeny N, Gordon M, Gasparetto C, Wong G, Sheridan C, Toner G, Meisenberg B, Botet J (1991) A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluoruracil in patients with gastrointestinal cancer. Blood 78 (6): 1420–1427
Crown J, Jakubowski A, Gabrilove J (1993) Interleukin-1: biological effects in human hematopoiesis. Leuk Lymphoma 9: 433–440
O’Neill LAJ (1995) Towards an understanding of the signal transduction pathways for interleukin-1. Biochim Biophys Acta 1266: 31–44
Mizel SB (1994) IL-1 signal transduction. Eur Cytokine Netw 5: 547–561
Rossi B (1993) IL-1 transduction signals. Eur Cytokine Netw 4: 181–187
Kuno K, Matsushima K (1994) The IL-1 receptor signaling pathway. J Leukoc Biol 56: 542–547
Rosoff PM (1990) IL-1 receptors: structure and signals. Seminars in Immunology 2:129–137
Rosoff PM (1989) Characterization of the interleukin-1-stimulated phospholipase C activity in human T lymphocytes. Lymphokine Res 8: 407–413
Schutze S, Machleidt T, Kronke M (1994) The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J Leukoc Biol 56: 533–541
Andrieu N, Salvayre R, Levade T (1994) Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor necrosis factor and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts. Biochem J 303: 341–345
Bomalaski JS, Steiner MR, Simon PL, Clark MA (1992) IL-1 increases phospholipase A2 activity, expression of phospholipase A2-activating protein, and release of linoleic acid from the murine T helper cell line EL-4. J Immunol 148: 155–160
Kolesnick R, Golde DW (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signalling. Cell 77: 325–328
Gronich J, Konieczkowski M, Gelb MH, Nemenoff RA, Sedor JR (1994) Interleukin-1a causes a rapid activation of cytosolic phospholipase A2 by phosphorylation in rat mesangial cells. J Clin Invest 93: 1224–1233
Mizel SB (1990) Cyclic AMP and interleukin-1 signal transduction. Immunol Today 11: 390–391
Munoz E, Beutner U, Zubiaga A, Huber BT (1990) IL-1 activates two separate signal transduction pathways in T helper type II cells. J Immunol 144: 964–969
Kester M, Siomonson MS, Mene P, Sedor JR (1989) Interleukin-1 generate transmembrane signals from phospholipids through novel pathways in cultured rat mesangial cells. J Clin Invest 83: 718–723
Mathias S, Younes A, Kan C-C, Orlow I, Joseph C, Kolesnick RN (1993) Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1[3. Science 259: 519–522
Huwiler A, Pfeilschifter J (1994) Interleukin-1 stimulates de novo synthesis of mitogenactivated protein kinase in glomerular mesangial cells. FEBS Leu 350: 135–138
Freshney NW, Rawlinson L, Guesdon F, Jones E, Cowley S, Hsuan J, Saklatvala J (1994) Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of hsp27. Cell 78 (6): 1039–1049
Kracht M, Truong O, Totty NF, Shiroo M, Saklatvala J (1994) Interleukin-1a activates two forms of p54α mitogen-activated proetin kinase in rabbit liver. J Exp Med 180: 2017–2027
Kuno K, Okamoto S, Hirose K, Murakami S, Matsushima K (1993) Structure and function of the intracellular portion of the mouse interleukin-1 receptor (Type I). J Biol Chem 268: 13510–13518
Croston GE, Cao Z, Goeddel DV (1995) NFKB activation by interleukin-1 requires an IL-1 receptor-associated protein kinase activity. J Biol Chem 270: 16514–16517
DiDonato JA, Mercurio F, Karin M (1995) Phosphorylation of IKBct precedes but is not sufficient for its dissociation from NFKB. Mol Cell Biol 15: 1302–1311
Bird TA, Sleath PR, de Roos PC, Dower SK, Virca GD (1991) Interleukin-1 represents a new modality for the activation of extracellular signal-related kinases/microtubuleassociated protein-2 kinases. J Bio Chem 266: 22661–22670
Galcheva-Gargova Z, Dérijard B, Wu I-H, Davis RJ (1994) An osmosensing signal transduction pathway in mammalian cells. Science 265: 806–809
Han J, Lee J-D, Bibbs L, Ulevitch RJ (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808–811
Shapiro L, Dinarello CA (1997) Cytokine expression during osmotic stress. Exp Cell Res 231: 354–362
Shapiro L, Dinarello CA (1995) Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci USA 92: 12230–12234
Muegge K, Williams TM, Kant J, Karin M, Chiu R, Schmidt A, Siebenlist U, Young HA, Durum SK (1989) Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1. Science 246 (4927): 249–251
Muegge K, Vila M, Gusella GL, Musso T, Herrlich P, Stein B, Durum SK (1993) IL-1 induction of the c-jun promoter. Proc Natl Acad Sci USA 90 (15): 7054–7058
Reimers JI, Bjerre U, Mandrup-Poulsen T, Nerup J (1994) Interleukin-113 induces diabetes and fever in normal rats by nitric oxide via induction of different nitric oxide synthases. Cytokine 6: 512–520
Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D (1995) A novel protein that interacts with thr death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270: 7795–7798
Engelmann H, Novick D, Wallach D (1990) Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 265: 1531–1536
van Antwerp DJ, Martin SJ, Vermna IM, Green DR (1998) Inhibition of TNF-induced apoptosis by NFKB. Trends Cell Biol 8: 107–111
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this chapter
Cite this chapter
Dinarello, C.A. (1999). Overview of inflammatory cytokines and their role in pain. In: Watkins, L.R., Maier, S.F. (eds) Cytokines and Pain. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8749-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8749-6_1
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9756-3
Online ISBN: 978-3-0348-8749-6
eBook Packages: Springer Book Archive